SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort

Identifying the potential for SARS-CoV-2 reinfection is crucial for understanding possible long-term epidemic dynamics. We analysed longitudinal PCR and serological testing data from a prospective cohort of 4,411 United States employees in 4 states between April 2020 and February 2021. We conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Finch, Emilie, Lowe, Rachel, Fischinger, Stephanie, de St Aubin, Michael, Siddiqui, Sameed M., Dayal, Diana, Loesche, Michael A., Rhee, Justin, Beger, Samuel, Hu, Yiyuan, Gluck, Matthew J., Mormann, Benjamin, Hasdianda, Mohammad A., Musk, Elon R., Alter, Galit, Menon, Anil S., Nilles, Eric J., Kucharski, Adam J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865659/
https://www.ncbi.nlm.nih.gov/pubmed/35143473
http://dx.doi.org/10.1371/journal.pbio.3001531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865659/
https://www.ncbi.nlm.nih.gov/pubmed/35143473
http://dx.doi.org/10.1371/journal.pbio.3001531

Ejemplares similares